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CD40 Triggering of Heterodimeric IL-12 p70
Production by Dendritic Cells In Vivo
Requires a Microbial Priming Signal
DNA containing CpG motifs (Fearon and Locksley,
1996). IL-12 production can also be elicited during the
interaction of MØ or DC with T cells, largely through
CD40 cross-linking on the accessory cell by CD40 ligand
(CD40L) expressed by the T cell (Gately et al., 1998;
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Trinchieri, 1998). The CD40 pathway has been thoughtLondon WC2A 3PX
to play a greater role than microbial stimulation in elic-United Kingdom
iting IL-12 production by DC, implying that the secretion† Immunobiology Section
of this cytokine by DC is primarily regulated by feedbackLaboratory of Parasitic Diseases
signals from activated T cells (Macatonia et al., 1995;National Institute of Allergy and Infectious Diseases
Cella et al., 1996; Koch et al., 1996). Although such aNational Institutes of Health
model neatly accounts for the potency of DC in inducingBethesda, Maryland 20892
Th1 differentiation, it also raises several questions. It
would be difficult to envisage DC priming of Th2 re-
sponses if T cell activation always led to IL-12 produc-Summary
tion via CD40/CD40L interactions. Moreover, activation
of bystander DC by activated T cells expressing CD40LCD40 ligation triggers IL-12 production by dendritic
(Koch et al., 1996) would lead to constitutive IL-12 pro-cells (DC) in vitro. Here, we demonstrate that CD40
duction.cross-linking alone is not sufficient to induce IL-12
In contrast, IL-12 production by DC in response toproduction by DC in vivo. Indeed, resting DC make
systemic injection of mice with STAg, an extract of theneither the IL-12 p35 nor IL-12 p40 subunits and ex-
parasite Toxoplasma gondii, is independent of CD40Lpress only low levels of CD40. Nevertheless, after DC
or other T cell–derived factors as it is not impaired inactivation by microbial stimuli that primarily upregu-
CD40L–/–, RAG–/–, or SCID mice (Reis e Sousa et al., 1997,late IL-12 p40 and augment CD40 expression, CD40
1999a). Having shown that microbial stimulation canligation induces a significant increase in IL-12 p35 and
elicit IL-12 in the absence of T cell signals, here we testIL-12 p70 heterodimer production. Similarly, IL-12 p70
the hypothesis that it also conditions CD40-driven IL-is produced during T cell activation in the presence
12 production by DC in vivo. We report that restingbut not in the absence of microbial stimuli. Thus, pro-
splenic DC do not express mRNA for either the regulatedduction of bioactive IL-12 by DC can be amplified by
IL-12 p40 or the “constitutive” IL-12 p35 subunit andT cell–derived signals but must be initiated by innate
express low levels of CD40. Treatment of mice with ansignals.
agonistic anti-CD40 antibody fails to elicit detectable
production of IL-12 by spleen cells or accumulation ofIntroduction
mRNA for either IL-12 subunit in DC. However, anti-
CD40 markedly synergizes with a microbial stimulus toInterleukin (IL)-12 is a critical cytokine in the initiation
induce IL-12 production in vivo, by increasing accumula-of innate and adaptive immune responses to many infec-
tion of IL-12 transcripts and protein in DC. Similarly,tions. It promotes cell-mediated responses, eliciting se-
stimulation of DC in culture with CD40L or antigen-acti-
cretion of IFN-g by NK and T cells and favoring the
vated T cells in the presence of microbial stimuli mark-
differentiation of precursor Th cells into Th1 effectors
edly augments IL-12 p70 production by DC compared
(Gately et al., 1998; Trinchieri, 1998). The IL-12 molecule to either stimulus alone. Thus, the production of high
is a heterodimer of 70 kDa consisting of two disulphide- levels of bioactive IL-12 by DC appears to be dependent
bonded subunits, IL-12 p40 and IL-12 p35, encoded by on two signals: a Th1-promoting innate stimulus that
separate genes, which must be expressed in the same primarily induces IL-12 p40 and induces CD40 expres-
cell to generate bioactive IL-12 (Gately et al., 1998; Trin- sion, and a signal through CD40, which is critical for
chieri, 1998). Most cell types express IL-12 p35 constitu- balanced production of the limiting subunit, IL-12 p35.
tively, whereas IL-12 p40 synthesis is inducible and re- However, the ability to respond to CD40 ligation in vivo
stricted to a subset of hematopoietic cells, including B is dependent on exposure to the innate signal. This non-
cells, macrophages (MØ), granulocytes, and dendritic reciprocal pattern of dependence and the resulting syn-
cells (DC) (D’Andrea et al., 1992; Gately et al., 1998; ergy between the two signals is likely to ensure that DC
Trinchieri, 1998). produce high levels of IL-12 p70 only during DC-T cell
Expression of IL-12 by MØ and DC can be induced interactions after the appropriate type of infection.
by stimuli derived from infectious organisms, including
intact bacteria, viruses, and protozoa (Gately et al., 1998; Results
Trinchieri, 1998). This appears to result from recognition
by those cells of molecular “signatures” of microbes, Resting DC Express Low Levels of CD40
such as LPS, double-stranded RNA, or unmethylated but Rapidly Upregulate the Molecule
after Microbial Stimulation In Vivo
In initial experiments, we failed to detect appreciable‡ To whom correspondence should be addressed (e-mail: caetano@
icrf.icnet.uk). surface levels of CD40 on DC freshly isolated from
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Figure 1. CD40 Is Expressed Constitutively Only at Low Levels on DC but Is Coinduced with IL-12 p40 on CD8a1 DC following STAg Challenge
In Vivo
Data in (A) represent ungated splenocytes; data in (B) and (C) are from CD11c1 cells selected by gating. Splenocytes from CBA/J mice injected
i.p. 6 hr previously with PBS or STAg (10 mg/mouse) were fixed, permeabilized, and stained for CD11c, CD8a and CD40 or IL-12 p40 (A and
B) or for CD11c, CD40 and IL-12 p40 (C). Arrows in (A) indicate CD11c1 splenocytes expressing CD40 or IL-12 p40 after STAg challenge. An
isotype-matched control antibody for anti-CD40 or anti-IL-12 p40 produced a staining pattern identical to that seen with the PBS control
(data not shown). Numbers in (B) indicate the frequency of DC in each quadrant. Data are from one of three experiments with similar results.
(D) Spleens from PBS- and STAg (25mg/mouse)-injected mice were taken 6 hr after injection, frozen, and then sectioned and stained for CD40.
Arrows indicate nests of CD40bright DC seen after STAg injection. No staining was seen using an isotype-matched rat IgG2a control antibody.
Original magnification: 1003.
spleen. As CD40 has been previously detected on DC correlation, demonstrating that they were coinduced in
the same cells (Figure 1C).in mouse spleen by immunohistochemical staining (Van
Den Berg et al., 1996), we stained permeabilized cells to To compare the kinetics of surface CD40 expression
and IL-12 production, mice were injected at differentdetermine if CD40 was sequestered in a DC intracellular
compartment. Even under these conditions, CD11c1 times with STAg and spleen cells were stained for CD40
or IL-12 p40. As shown in Figure 2A, both CD8a2 andspleen cells failed to stain with anti-CD40, despite obvi-
ous labeling of a significant fraction of CD11c2 cells in CD8a1 DC expressed low constitutive surface levels of
CD40, markedly below those found on B cells. CD40the same sample, corresponding to B cells (Figures 1A
and 1B: PBS). To examine if CD40 levels were upregu- was very rapidly upregulated on CD8a1 DC after STAg
challenge, its detection lagging only slightly behind thatlated upon DC activation, we measured CD40 on cells
from STAg-injected mice. In contrast to control cells, a of IL-12 p40, and reached maximal levels of expression
substantially higher than those on B cells (Figures 2Asignificant proportion of CD11c1 cells from STAg-
treated animals stained for CD40, roughly similar to the and 2B). CD40 and IL-12 p40 levels were downregulated
by 24 hr postinjection (Figures 2A and 2B), consistentproportion of cells that stained for IL-12 p40 (Figure 1A,
STAg, arrows). CD40 expression by DC could also be with the transient nature of CD8a1 DC activation by
STAg (Reis e Sousa et al., 1997, 1999a). STAg also in-detected in sections of spleen from STAg-treated but
not control mice (Figure 1D) and colocalized with IL- creased CD40 expression on CD8a2 DC but did not alter
CD40 expression by B cells (Figure 2A).12 p40 immunoreactivity (data not shown). CD40 was
upregulated on all DC but most noticeably on the CD8a1 Other microbial stimuli were tested to examine if the
upregulation of CD40 was confined to STAg treatment.DC subset, which also selectively produces IL-12 p40
in response to STAg (Figure 1B). About half of the CD8a1 Injection of LPS or CpG-containing oligonucleotides
similarly induced CD40 expression on both DC popula-DC stained for IL-12 p40 or CD40 (Figure 1B). Simultane-
ous staining for the two markers showed an absolute tions, although, as with STAg, upregulation was most
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Figure 2. Time Course of CD40 Upregulation
on CD8a1 and CD8a2 DC Subsets
(A and B) Comparison of resting and STAg-
induced levels of CD40 (A) and IL-12 p40 (B)
expression on DC subsets and B cells. Sple-
nocytes were prepared from mice (BALB/c)
that had been injected with STAg (10 mg/
mouse, i.p.) at different times. Splenocytes
were stained live for CD40 or after fixation
and permeabilization for IL-12 p40. DC sub-
sets were analyzed by first gating on CD11c1
MHC class II1 double positive cells, followed
by subset-specific gates based on CD8a his-
tograms; B cells were defined as CD11c2
MHC class II1 cells. Data are the difference in
median fluorescence intensity (MFI) between
the specific antibody and an isotype-matched
control. Time shown is the total length of ex-
posure to STAg in vivo. The 0 hr time point
corresponds to a PBS-injected control.
(C and D) Upregulation of CD40 on DC sub-
sets following LPS or CpG DNA challenge.
BALB/c mice were injected i.p. for 6 hr (C)
with PBS, STAg (10 mg), or LPS (1 mg) or i.v.
for 4.5 hr (D) with PBS or CpG DNA (100
mg). CD40 staining of CD8a1 CD11c1 or
CD8a2CD11c1 cells is shown.
(E) Spontaneous and STAg-induced expres-
sion of CD40 on CD8a1 and CD8a2 DC in
vitro. Splenocytes from untreated mice
(BALB/c) were incubated at 107 cells/well in
the absence or presence of STAg (5 mg/ml)
and were fixed, stained, and analysed as in
(A) and (B). Data are representative of three
(A, B, D, and E) or two (C) experiments.
prominent in the CD8a1 DC subset (Figures 2C and 2D). ion by anti-CD40L and could be mimicked with anti-
CD40 agonistic antibodies (data not shown). Using in-We conclude that resting DC in spleen constitutively
express very low levels of CD40, but this receptor can tracellular cytokine staining for the p40 subunit, the
synergy between microbial stimulation and CD40 liga-be rapidly upregulated, particularly on CD8a1 DC, after
activation by microbial stimuli. tion was attributed to both an increase in the proportion
of DC making IL-12 and an increase in the amount of
subunit made per cell (data not shown).CD40 Triggering Synergizes with Microbial
Stimulation to Elicit High Levels of IL-12 Much of the IL-12 produced by spleen cells appeared
to come from CD8a1 DC, as depletion with either anti-p70 Production by DC In Vitro
The upregulation of CD40 in response to microbial acti- CD11c or anti-CD8a largely abrogated cytokine detec-
tion (Figures 3A and 3B). Confirming this, purified CD8a1vation suggested that CD40 triggering might potentiate
IL-12 production initiated by the microbial challenge. To and CD8a2 DC both produced IL-12 p40 and p70 in
response to CD40L (Figures 3C and 3D). Only CD8a1test this hypothesis, we stimulated spleen cells in vitro
with CD40L-transfected fibroblasts in the presence or DC responded to STAg, as reported (Reis e Sousa et
al., 1997, 1999a), although both subsets made IL-12 p40absence of STAg or CpG DNA and measured IL-12 accu-
mulation in supernatants. Spleen cells incubated with and p70 in response to the combination of STAg 1
CD40L (Figures 3C and 3D). Similarly, both subsets re-NIH 3T3 control fibroblasts did not make appreciable
levels of IL-12 p40 or p70 (Figures 3A and 3B). As ex- sponded to CpG DNA 6 CD40L (Figures 3C and 3D).
The synergy between CD40 cross-linking and microbialpected, IL-12 p40 and p70 were produced following
stimulation with STAg or CpG DNA (Figures 3A and 3B). stimulation was very marked, resulting in accumulation
of high levels of IL-12 p70 in culture supernatants (0.15–Surprisingly, given the absence of significant CD40 ex-
pression by DC (see above), IL-12 p40 and p70 were 0.2 pg IL-12 p70 per DC in 24 hr; Figures 3D and 3F). This
was not due to increased survival of IL-12-producing DCalso produced in response to incubation with CD40L-
expressing fibroblasts (Figures 3A and 3B). However, in culture or to a change in the kinetics of cytokine
production (data not shown). It was also not due to IFN-gthe combination of CD40L stimulation and STAg or CpG
DNA was markedly better than either stimulus alone, production in response to the microbial stimulus as no
difference was detected between spleen cells fromincreasing IL-12 accumulation by 10-fold or more (Fig-
ures 3A and 3B). A similar increase was seen with heat- IFN-g sufficient versus IFN-g2/2 mice (data not shown).
Compared to DC, neither MØ nor B cells made apprecia-killed Brucella abortus plus CD40L stimulation (data not
shown). The effect of CD40L-transfected fibroblasts ble levels of IL-12 p40 or p70 in response to the same
stimuli (Figures 3E and 3F). We conclude that CD40could be specifically blocked in a dose-dependent fash-
Immunity
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Figure 3. CD40L Synergizes with STAg or
CpG DNA to Induce High Levels of IL-12 Pro-
duction by DC
(A and B) Whole spleen cell suspensions were
mock-depleted with streptavidin-conjugated
magnetic beads or were depleted with anti-
CD11c or anti-CD8a-conjugated magnetic
beads and cultured at 2 3 105/well with
CD40L-expressing (CD40L) or control fibro-
blasts (control), either alone or in the pres-
ence of STAg (5 mg/ml) or CpG DNA (“oligo”,
0.25 mg/ml).
(C and D) Purified DC subsets were cultured
at 2 3 104/well with fibroblasts and stimuli as
in (A) and (B).
(E and F) CD11c-enriched cells (2.5 3 104/
well), purified splenic B cells (5 3 104/well),
and RAW-264.7 cells (MØ, 2.5 3 104/well)
were cultured with fibroblasts and stimuli as
in (A) and (B). 24 hr culture supernatants were
assayed for IL-12 p40 (A, C, and E) and IL-12
p70 (B, D, and F) by ELISA. In (E) and (F), IL-
12 production was adjusted for the number
of leukocytes per well.
Data are the mean of triplicate wells. All error
bars are shown and represent one SD from
the mean. Where no bar is seen, IL-12 levels
were below the detection threshold of the
ELISA. Cultures without fibroblasts yielded
identical results to those with control fibro-
blasts and are omitted for the sake of clarity.
Neither fibroblast line produced IL-12 in re-
sponse to STAg or CpG DNA. Data are from
one representative experiment of fifteen per-
formed with spleen cells, three (STAg) or two
(CpG DNA) performed with purified DC, and
three experiments with CD11c-enriched/B
cells/MØ.
triggering and microbial stimulation synergize to elicit levels (Figures 4A and 4B, PBS group), confirming that
IL-12 production by DC in vitro in response to CD40the production of high levels of IL-12 by splenic DC.
cross-linking is likely to be an artifact. Injection of STAg
with a control antibody induced production of high levels
of IL-12 p40 and some IL-12 p70 (Figures 4A and 4B),Anti-CD40 Fails to Trigger IL-12 Synthesis by DC
In Vivo but Synergizes with STAg to Augment as expected (Reis e Sousa et al., 1997). As predicted,
addition of anti-CD40 to the STAg inoculum greatly in-IL-12 p70 Production
The ability of CD40L alone to elicit IL-12 production by creased p70 levels produced by isolated spleen cells
and had a more modest effect on IL-12 p40 (FiguresDC (Figure 3) is consistent with previous reports (Cella
et al., 1996; Koch et al., 1996) but was surprising consid- 4A and 4B). Depletion of CD11c1 cells prior to culture
resulted in .90% reduction in IL-12 detection, indicatingering our failure to detect CD40 on these cells in the
absence of microbial stimulation (Figures 1 and 2A). A that, in vivo as well as in vitro, DC were the major source
of IL-12 p70 in response to the two stimuli (data notpossible explanation for this discrepancy came from the
observation that CD40 is spontaneously upregulated by shown). The production of IFN-g in the spleen cell cul-
tures correlated with the measured levels of IL-12 p70,DC in culture (Figure 2E), as reported (Inaba et al., 1994).
Consistent with the results obtained in vivo, STAg accel- indicating that the cytokine was bioactive (Figure 4C).
Interestingly, LPS and anti-CD40 coadministration failederated the spontaneous CD40 upregulation by both
CD8a1 and CD8a2 DC in culture and promoted higher to induce substantial levels of IL-12 production (Figures
4A and 4B), despite the fact that the endotoxin upregu-levels of expression (Figures 2C and 2A).
These observations suggested that the isolation and lated CD40 on DC to a similar or greater extent than
STAg (Figure 2C). Nevertheless, LPS 1 anti-CD40 didculture of DC mimicked innate activation in vivo, leading
to CD40 upregulation and responsiveness to CD40L cause a slight increase in the amount of IFN-g detected
in spleen cell cultures (Figure 4C).stimulation. This hypothesis predicted that CD40 cross-
linking by itself should fail to elicit IL-12 production by To determine if the splenic response was representa-
tive of the total response in the mouse, levels of circulat-DC in vivo but should still synergize with microbial stimu-
lation to amplify cytokine levels, as seen in vitro. Indeed, ing IL-12 p70 were measured in the serum 24 hr after
treatment. Anti-CD40 treatment alone elicited signifi-spleen cells from mice injected with agonistic anti-CD40
alone did not make IL-12 p40 or p70 above background cantly lower levels of circulating IL-12 p70 than STAg,
Microbial Priming for IL-12 p70 Production
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Figure 4. CD40 Cross-Linking In Vivo Re-
quires an Innate Stimulus to Promote IL-12
Production by Splenocytes
Spleen cells were prepared from mice 6 hr
after i.v. injection with anti-CD40 mAb or an
isotype-matched control mAb, used alone or
in combination with STAg, LPS or PBS (vehi-
cle). The cells were cultured overnight at 5 3
105/well, and levels of IL-12 p40 (A), IL-12 p70
(B), and IFN-g (C) were determined in culture
supernatants by ELISA. Data shown are the
mean of triplicate cultures. All error bars are
shown and represent one SD from the mean.
One of three experiments with similar results.
as expected (Table 1). Addition of anti-CD40 to STAg splenic DC was at least 300-fold lower than that in total
spleen cells (data not shown). STAg treatment causedcaused a more than 10-fold increase in IL-12 p70 levels,
leading to extremely high serum concentrations of the marked upregulation of IL-12 p40 message and a small
increase in IL-12 p35 (Figure 5B), consistent with thecytokine (Table 1). This increase in serum IL-12 p70 was
also reflected in an increase in circulating IFN-g (data ability of that microbial stimulus to induce high levels
of IL-12 p40 and low levels of IL-12 p70. Anti-CD40not shown). Thus, the systemic response to anti-CD40
and STAg stimulation is broadly similar to the response treatment alone did not induce expression of either sub-
unit in DC (Figure 5B), confirming ELISA data (seeof DC in the spleen. We conclude that anti-CD40 is
insufficient to elicit IL-12 p70 in vivo but synergizes with above). However, the addition of anti-CD40 to the STAg
stimulus caused a significant increase in IL-12 p35 and,certain types of microbial stimuli to promote high levels
of bioactive IL-12 production by DC. less noticeably, in IL-12 p40 message (Figure 5B).
Real-time PCR was carried out to quantitate the
upregulation of IL-12 p35 message in DC, using theSynergy between CD40 Cross-Linking and STAg
amount of message for the housekeeping gene GAPDHfor IL-12 p70 Production Is Due to Increased
as an internal calibration control (Figures 5C and 5D).Expression of IL-12 p35
Confirming the semiquantitative PCR studies, IL-12 p35To investigate the mechanism by which STAg and anti-
message levels in DC were not changed following injec-CD40 synergize to promote production of high levels of
tion of anti-CD40 (Figures 5C–5E). STAg challenge in-IL-12 p70, we examined the expression of mRNA for the
creased IL-12 p35 levels by 70-fold but the addition ofIL-12 p40 and IL-12 p35 genes in cells from mice treated
anti-CD40 to STAg caused an increase of 400-fold, fivewith one or both stimuli. Semiquantitative PCR of total
times more message than upon challenge with the mi-spleen cell cDNA showed that IL-12 p35 mRNA was
crobial stimulus alone (Figure 5E). Thus, the ability ofpresent constitutively in the spleen and was not signifi-
CD40 cross-linking to synergize with STAg in promotingcantly affected by any of the treatments (Figure 5A).
production of IL-12 p70 appears to be due to the abilityMessage for IL-12 p40 was absent in control mice (Fig-
of the combined stimuli to upregulate DC expression ofure 5A). Anti-CD40 treatment alone did not alter the
the limiting IL-12 p35 subunit and partially correct thelevels of IL-12 p40 mRNA but STAg stimulation strongly
unbalanced production of p40 that is induced by theinduced its accumulation (Figure 5A). STAg 1 anti-CD40
microbial stimulus alone.treatment was comparable to STAg alone (Figure 5A).
Unlike bulk splenocytes, DC from control mice did not
contain appreciable levels of mRNA for IL-12 p35 (Figure
T Cells Substitute for CD40L in Synergizing5B). Quantitative PCR measurements (see below) indi-
with STAg to Elicit IL-12 p70 Productioncated that the level of IL-12 p35 message in resting
In physiological situations, cross-linking of CD40 on DC
is likely to be triggered by CD40L expressed on activated
T cells (Banchereau et al., 1994; Grewal and Flavell,
Table 1. Anti-CD40 Greatly Augments the Systemic IL-12
1998). To determine if the above findings could be repli-Response Induced by STAg
cated in a model of T cell activation, we analyzed IL-12
Inoculum production in APC-T cell cocultures. Total spleen cells
mAb STAg IL-12 p70 (ng/ml) from DO-11.10 TCR (anti-OVA 323–339 1 I-Ad) trans-
genic mice on a BALB/c-scid background were culturedcontrol 2 0 6 0
for 24 hr with a titration of antigen 6 STAg. The presencecontrol 1 11.7 6 4.3
of STAg did not alter the dose response of T cells toanti-CD40 2 2.9 6 0.5
anti-CD40 1 134.2 6 34.6 antigen, as measured by CD69 upregulation (data not
shown). However, in the absence of STAg, T cell activa-Serum samples were prepared from mice 24 hr after i.v. challenge,
tion resulted in only very low levels of IL-12 p40 produc-and IL-12 p70 levels were determined by ELISA. Data represent the
average 6 SD of three mice per group, each sample measured in tion by APC and undetectable IL-12 p70 accumulation
triplicate. Similar results were observed in a further three experi- (Figures 6A and 6B). Addition of STAg to the cultures
ments in which the length of challenge was varied (3 hr, 6 hr, and induced IL-12 p40 and IL-12 p70, as expected, but also
48 hr).
allowed T cell activation to result in production of bioac-
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Figure 5. IL-12 p40 and IL-12 p35 Are Ex-
pressed De Novo in DC upon Stimulation but
Regulated Differentially in Response to STAg
and Anti-CD40 Cross-Linking
(A and B) Semiquantitative RT-PCR of IL-12
p40 and IL-12 p35 was performed on total
RNA samples from whole splenocytes (A) and
FACS sorted DC (B). The cells were prepared
3 hr after i.v. injection of mice with PBS, STAg,
anti-CD40, or STAg 1 anti-CD40, as indi-
cated. Molecular weight markers (100 bp lad-
der) are shown on the left.
(C–E) Real-time PCR analysis of IL-12 p35
expression by purified DC. Amplification
plots for IL-12 p35 (C) or GAPDH (D) show
the increase in SYBR Green fluorescence for
each cDNA sample, in triplicate runs. Thresh-
old cycle (CT) values for each sample were
taken from the linear part of the amplification
plots, as indicated by the dotted horizontal
lines. CT values were converted by compari-
son to the respective standard curves (data
not shown), and the amount of IL-12 p35
cDNA was normalized to that of GAPDH.
(E) Normalized IL-12 p35 levels are expressed
as the mean of triplicate determinations rela-
tive to the level of IL-12 p35 in the PBS control
sample. All error bars are shown and repre-
sent one SD from the mean. Data are from
one of two experiments with similar results.
tive IL-12 p70 (Figures 6A and 6B). Indeed, titration of this cytokine in a unique position at the interface of the
innate and adaptive immune systems (Gately et al., 1998;peptide into STAg-containing cultures increased IL-12
Trinchieri, 1998). However, the regulation of IL-12 pro-p70 production by up to 15- to 25-fold without signifi-
duction in vivo is still poorly understood. Measurementscantly affecting IL-12 p40 production (Figures 6A and
of IL-12 are complicated by the fact that the bioactive6B). Anti-CD40L blocked the increase in IL-12 p70 by
molecule is a heterodimer normally found in the context.50% (data not shown). Thus, the requirement for mi-
of a substantial excess of the p40 subunit (Gately et al.,crobial priming also applies when using activated T cells
1998; Trinchieri, 1998). Based on studies looking mainlyas a physiological stimulus for IL-12 production by APC.
at IL-12 p40 produced in response to the parasite Tox-
oplasma gondii and its products, we have previouslyDiscussion
proposed that DC are the major sources of IL-12 in vivo
(Reis e Sousa et al., 1997, 1999a; Sher and Reis e Sousa,The ability of IL-12 to elicit innate resistance to infection,
1998). Here, we present further evidence for this notionas well as to promote cell-mediated immunity, places
and demonstrate that production of IL-12 p70 hetero-
dimer by DC involves regulation of the p35 and p40
genes by both microbial and T cell–derived stimuli. Al-
though we observe IL-12 p70 production in response to
STAg, CpG DNA or Brucella abortus organisms alone,
maximal levels of bioactive cytokine are produced only
after the cells receive a second signal through CD40.
Importantly, we find that the ability of DC to respond
to the second signal is dependent on exposure to the
microbial stimulus, which regulates the expression of
CD40 and conditions the response. Thus, IL-12 produc-
tion by DC in vivo can be amplified by CD40L provided
endogenously but remains strictly under the control of
exogenous signals received through the innate immuneFigure 6. Microbial Stimulation Is Required to Induce IL-12 Produc-
tion during T Cell Activation system (Janeway, 1989).
There are many reports on the ability of CD40 cross-Production of IL-12 p40 (A) and IL-12 p70 (B) by splenocytes from
DO11.10-scid mice following stimulation with antigen in the pres- linking to induce IL-12 production by DC (Cella et al.,
ence (filled circles) and absence (open circles) of STAg. The cells 1996; Koch et al., 1996; Banchereau et al., 2000). Al-
were cultured overnight at 2 3 105/well and levels of cytokines were though we confirm this is true in vitro (Figure 3), it is
measured in the culture supernatants by ELISA. Levels of IL-12 p70
also clear from our analysis that CD40 cross-linkingin cultures without STAg were below the detection threshold of the
agents by themselves do not elicit IL-12 production byassay (# 20 pg/ml). Data represent the mean of triplicate wells from
DC in vivo. Thus, we believe that previous observationsone out of three experiments with identical results. All error bars
are shown and represent one SD from the mean. of IL-12 production by DC in vitro in response to CD40
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triggering are due to priming of DC during isolation or mented by coadministration of an appropriate microbial
adjuvant.the use of DC grown from progenitors under conditions
that provide the necessary costimuli. Interestingly, the A separate question is whether CD40 upregulation
by DC is sufficient to mediate IL-12 p70 production inspontaneous activation of splenic DC in culture (Figure
2E) is sufficient to lead to production of IL-12 p70 in response to anti-CD40. LPS, a stimulus that upregulates
CD40 to the same extent as STAg (Figure 2C), failed toresponse to supraphysiological CD40 cross-linking by
CD40L expressed at high levels on fibroblasts (Figure prime DC for high-level IL-12 p70 production in response
to anti-CD40 (Figure 4). It is possible that this is due to3) but not in response to physiological feedback stimuli
generated during activation of naive T cells (Figure 6). the dual nature of LPS stimulation, which causes IL-12
p40 mRNA and protein accumulation in DC in vivo (BetteThese observations reinforce the concept that microbial
priming is necessary for IL-12 production by DC in a et al., 1994; Reis e Sousa et al., 1997; O. S. and C. R. S.,
unpublished data) but also rapidly induces DC apoptosisphysiological context.
The notion that optimal production of IL-12 p70 by (De Smedt et al., 1996) and abrogates the response to
STAg (Reis e Sousa et al., 1999a). Alternatively, it isDC involves synergy between CD40 cross-linking and
microbial stimulation is compatible with studies of hu- conceivable that stimuli such as STAg, Brucella, or CpG
DNA not only upregulate CD40 but also influence down-man DC in vitro showing that the interaction between T
cells and APC is not sufficient to induce high levels of stream responses to CD40 signaling to generate IL-12
p70. These considerations are relevant to the mecha-IL-12 production unless microbial stimuli and/or cyto-
kines are added or are produced by the T cells them- nism by which DC induce Th2 responses (Kalinski et al.,
1999; Reis e Sousa et al., 1999b). Th2-promoting stimuliselves (Hilkens et al., 1997; Snijders et al., 1998).
Whether CD40 signaling in our experiments directly pro- may fail to promote CD40 upregulation on DC in vivo or
may condition the DC so that CD40 signaling does notmotes IL-12 synthesis by DC or whether it causes pro-
duction of an autocrine IL-12-inducing factor remains result in high levels of bioactive IL-12 p70 production.
These possibilities are currently under investigation.to be established. For example, IFN-g is a critical cofac-
tor for IL-12 production by human monocyte-derived There has been recent interest in the role of DC sub-
sets in determining the class of emerging T cell re-DC (Hilkens et al., 1997; Snijders et al., 1998; Vieira et
al., 2000). Nevertheless, a role for IFN-g can be excluded sponse. Observations in the mouse and human have
suggested that CD8a1 DC and monocyte-derived DC,in our experiments because both the STAg-induced
IL-12 production and synergy between microbial stimu- respectively, are uniquely able to produce IL-12 and
prime a Th1 response (reviewed in Banchereau et al.,lation and CD40 cross-linking are not diminished in
IFN-g2/2 mice (Reis e Sousa et al., 1997; data not shown). 2000). Indeed, CD8a1 DC are the only cells in the spleen
that produce IL-12 upon primary STAg challenge (ReisThis makes biological sense because a primary function
of IL-12 p70 is to elicit IFN-g, and it would otherwise be e Sousa et al., 1997, 1999a). Nonetheless, here we find
that CD8a2 DC are clearly able to produce both IL-12difficult to envisage how IL-12 p70 production could be
initiated early in an immune response, before IFN-g is p40 and p70 after stimulation with microbial products
plus CD40L (Figure 3). The CD8a2 DC subset can alsoavailable. Similarly, IL-12 itself has been reported to
prime DC for its own production in response to LPS make the cytokine upon in vivo priming and in vitro
restimulation (Reis e Sousa et al., 1999a). Therefore, we(Grohmann et al., 1998) but this would require a non-
DC as the initiating source of the cytokine. Our findings subscribe to the view that both subsets can prime Th1
responses but that they may be activated by differentsuggest that bioactive IL-12 can be synthesized by DC
early during T cell priming, in the absence of a third cell stimuli. Consistent with this notion, CD8a2 DC always
respond better to CpG DNA than to STAg, while theand before precursor Th cells have differentiated into
IFN-g-producing Th1 cells. converse is true for CD8a1 DC (Figures 3C and 3D).
Although in both cases CD8a1 DC make higher levelsWe find that constitutive CD40 expression by primary
DC in secondary lymphoid tissues is very low. Other of IL-12 than the CD8a2 subset (Figure 3), this could be
due in part to greater heterogeneity in the CD8a2 DCstudies also support this notion (Inaba et al., 1994; Ruedl
and Bachmann, 1999), although, in apparent contradic- compartment (Vremec et al., 2000).
IL-12 p35 is generally expressed constitutively bytion, some have shown CD40 expression on murine and
human spleen DC (Banchereau et al., 1994; Van Den most cells (D’Andrea et al., 1992; Gately et al., 1998;
Trinchieri, 1998), and we find message for this subunitBerg et al., 1996; Anjue`re et al., 1999). Such reports
of CD40 expression by splenic DC may reflect a few in spleen (Figure 5A), as reported (Bette et al., 1994).
However, levels of IL-12 p35 mRNA were exceedinglyactivated cells and/or an ongoing pathological process
or may be due to spontaneous upregulation of this mole- low in purified resting DC until upregulated by activation
(Figure 5B). Thus, in common with human blood mono-cule upon DC isolation, as we observed (Figure 2E). In
our experiments, CD40 expression by DC in vivo was cytes (Snijders et al., 1996), murine splenic DC regulate
both IL-12 subunits and express neither one in a consti-induced by challenge with microbial agents (Figure 2).
DNA vaccination also increases CD40 expression by DC tutive manner. Interestingly, rat respiratory tract DC can
also regulate both IL-12 subunits independently (Stum-in draining lymph nodes (Akbari et al., 1999), similar to
the effect we see in splenic DC with CpG-containing bles et al., 1998), suggesting that this could be true of
most DC isolated from tissues. STAg by itself upregu-oligonucleotides (Figure 2D). These results have impor-
tant implications for the use of anti-CD40 mAbs in immu- lates both IL-12 p35 and p40 subunits and induces low
levels of IL-12 p70 production by DC (Figures 4 and 5).notherapy (Diehl et al., 1999; French et al., 1999; Soto-
mayor et al., 1999) as they suggest that, in some cases, This does not appear to be an indirect effect of a low
level of CD40 cross-linking in vivo because we havethe potency of these reagents in vivo could be aug-
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ing unit of the Imperial Cancer Research Fund (Clare Hall, Southfailed to see any reduction in serum IL-12 p70 levels
Mimms, UK). BALB/c, C57BL/6, B10.BR, and CBA mice were usedelicited by STAg in mice lacking T cells, CD40, or CD40L
interchangeably as the response to the stimuli used was similar for(unpublished data). Interestingly, CD40 triggering has
all mouse strains tested. DO-11.10 mice (Murphy et al., 1990) on a
been primarily implicated in upregulation of IL-12 p40, BALB/c-scid background were a gift from Dr. Paul Garside, Univer-
with very little effect reported on IL-12 p35 mRNA levels sity of Glasgow.
in human B lymphoblast and monocytic cell lines or
in mouse MØ (Kato et al., 1996; Yamane et al., 1999). Reagents
Soluble tachyzoite antigen (STAg) was prepared from tachyzoitesHowever, regulation of the p40 subunit by CD40 is less
of the RH 88 strain of T. gondii, as described previously (Grunvaldcritical in our experiments, given the large excess of IL-
et al., 1996). STAg was administered to mice i.v. or i.p. at a dose of12 p40 message induced by microbial stimulation. Thus,
10 or 25 mg per mouse in 200 ml PBS. PBS was used as a vehiclethe synergy we observe is likely to be due to the ability
alone control. Lipopolysaccharide (LPS) was obtained from Sigma
of CD40 ligation to upregulate the limiting IL-12 p35 (Poole, UK) and used at 1 mg/mouse for in vivo experiments. Heat-
message. Interestingly, the ability of feedback stimuli killed Brucella abortus was a gift from Dr. D. Scott, FDA. The CpG-
from T cells to increase STAg-induced IL-12 production containing DNA had the sequence TCCATGACGTTCCTGATGCT
(Krieg et al., 1995) and was made as a phosphorothioate-linkedmay also be due to effects on the IL-12 p35 subunit
oligonucleotide by the ICRF oligonucleotide synthesis service (Clare(Yamane et al., 1999) because increased antigen stimu-
Hall Laboratories, South Mimms, UK). The ovalbumin peptide 323–lation resulted in increased production of IL-12 p70 with-
339 (OVA peptide; ISQAVHAAHAEINEAGR) was made by the ICRF
out a similar increase in IL-12 p40 (Figure 6). peptide synthesis service. mAbs used for in vivo treatment were
The ability to respond to CD40 cross-linking is an anti-CD40 mAb (clone 3/23 (Hasbold et al., 1994), Pharmingen, San
important feature of DC biology in aspects other than Diego, CA, or FGK-45 (Rolink et al., 1996), kind gift from Dr. A.
Rolink, Basel, Switzerland) and an isotype matched (rat IgG2a) con-cytokine production. Signaling through CD40 can upreg-
trol antibody (clone R35-95, Pharmingen). STAg, CpG DNA, OVAulate antigen presentation, increase expression of co-
peptide, and mAbs were rigorously tested and found to be free ofstimulatory molecules, and make DC competent for CTL
endotoxin contamination.priming (reviewed in Banchereau et al., 2000). Thus, the
ability of DC to stimulate T cells and induce CD40L
Cellsexpression and of CD40 cross-linking to modulate APC The cell lines 3T3-CD40L and 3T3-SAMEN were kind gifts from Drs.
function is likely to result in a positive feedback loop, R. Lapointe and P. Hwu (NCI, Bethesda, MD). 3T3-CD40L has been
which leads to full activation of both leukocytes. In line derived from the mouse fibroblast cell line NIH 3T3 by stable trans-
with this notion, mice deficient in either CD40 or CD40L duction with a retroviral vector containing the gene for murine CD40L
under the control of the CMV promoter. The line 3T3-SAMEN (re-show profound defects in some adaptive immune re-
ferred throughout as “control”) was retrovirally transduced with thesponses (Grewal and Flavell, 1998), although it is likely
empty vector. Surface expression of CD40L on 3T3-CD40L but notthat other APC receptors with similar functions (e.g.,
on 3T3-SAMEN was confirmed by flow cytometry.
TRANCE receptor [Josien et al., 1999]) may substitute Spleen cell suspensions were prepared initially by collagenase/
for CD40 in some responses, consistent with the fact DNaseI digestion (Reis e Sousa et al., 1997, 1999a). However, be-
that anti-CD40L antibodies do not completely block IL- cause commercial stocks of collagenase are contaminated with
12 production in response to STAg 1 T cell activation high levels of endotoxin, in later experiments Liberase CI (Roche
Diagnostics Ltd., Lewes UK) was substituted for collagenase. Liber-(O. S., S. M., A. D. E., and C. R. S., unpublished data).
ase working solutions contain ,0.5 endotoxin units/ml.However, the ability of T cells to activate APC would
Splenic DC or DC subsets were isolated in two steps. First,be counterproductive in the absence of further regula-
CD11c1 DC were enriched by MACS with anti-CD11c magnetic
tion. A CD40L-expressing T cell could activate by- beads (Miltenyi Biotec Ltd., Bisley, UK) using positive selection col-
stander APC in noncognate fashion (Koch et al., 1996), umns. DC enriched populations were then stained with PE-labeled
in a wasteful and potentially harmful manner. Cognate anti-CD11c and, if required, FITC-labeled anti-CD8a. CD8a1/CD8a2
DC subsets or total DC were sorted on a FACS Vantage (Becton-interactions due to low-affinity cross-reactivity with self-
Dickinson, Mountain View, CA) using TOPRO (Molecular Probesantigens could be even more dangerous, as they might
Europe BV, Leiden, The Netherlands) staining to exclude dead cells.increase antigen presentation (Manickasingham and
This method resulted in DC enrichment from 2%–3% in the startingReis e Sousa, 2000) and initiate autoimmune phenom-
material to 70%–80% after MACS and .96% purity after FACS.
ena. Viewed in this context, the low constitutive level of B cells were purified from total spleen suspensions by staining
CD40 expression (and, perhaps, of other receptors for with PE-labeled anti-CD11c and FITC-labeled anti-B220 and sorting
T cell–derived stimuli) on DC would seem absolutely B2201 CD11c2 cells on a FACS Vantage. Greater than 97% of the
sorted population were B2201 and less than 0.3% expressed CD11c.crucial to maintain these APC in a resting state in the
The RAW-264.7 MØ cell line was obtained from ATCC.absence of infection. Anti-CD40 treatment in vivo can
potentiate expression of costimulatory molecules on DC
Spleen Cell Cultures and Cytokine Assaysbut, again, cannot act in the absence of innate DC activa-
For in vitro stimulation, splenocytes, macrophages, sorted DC, ortion (A. D. E., O. S., and C. R. S., unpublished data). It
B cells were cultured in 96-well flat bottom culture plates on aappears, therefore, that cross-linking of CD40 is a major
monolayer of either CD40L or control fibroblasts, which had been
mechanism for amplifying APC delivery of signals 1 (anti- plated the previous day at a density of 104 cells per well. Alterna-
gen), 2 (costimulation), and 3 (immunomodulatory cyto- tively, total spleen cells from DO-11.10/scid mice were used at 2 3
kines) to T cells but that it acts only after initial APC 105/well. Cultures were then incubated in the absence or presence
of STAg or CpG DNA, in RPMI 1640 medium supplemented with 10%activation by a microbial stimulus.
FCS, penicillin (100 units/ml), streptomycin (100 mg/ml), glutamine (2
mM), and 2-mercaptoethanol (5 3 1025 M). Culture supernatantsExperimental Procedures
were collected at 18–24 hr and assayed for IL-12 p40, IL-12 p70,
and IFN-g production using a sandwich ELISA, as described (ReisAnimals
e Sousa et al., 1997, 1999a). Antibody pairs were (from PharMingen,Male and female 6- to 10-week-old mice were obtained from a
commercial supplier (Charles River, Margate, UK) or from the breed- unless otherwise indicated; name of capture mAb followed by name
Microbial Priming for IL-12 p70 Production
461
of detection mAb): C15.6, C17.8 (biotinylated) for IL-12 p40; 9A5, for their expert assistance and animal care. We thank Fran Balkwill,
Doreen Cantrell, Ron Germain, Catharien Hilkens, Nancy Hogg, MikeC17.8 (biotinylated) for IL-12 p70; XMG1.2, rabbit anti-IFN-g antise-
rum (kind gift from Dr. W. E. Paul, NIH, Bethesda, MD) 1 biotinylated Owen, and members of the Immunobiology Laboratory, Imperial
Cancer Research Fund, for helpful discussions and for commentsmouse anti-rabbit (Jackson ImmunoResearch, West Grove, PA) for
IFN-g. on the manuscript.
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